NCT07152782 2025-09-03
THUNDER
Fudan University
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT07019272 2025-06-13
Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study
Hebei Medical University Fourth Hospital
Not yet recruiting
NCT05491057 2022-08-08
Treatment Patterns of Neratinib in HER2+ EBC in China
Pierre Fabre Medicament
Not yet recruiting